Adoptive transfer of heme oxygenase-1 (Ho-1)–modified macrophages rescues the nuclear factor erythroid 2–related factor (Nrf2) antiinflammatory phenotype in liver ischemia/reperfusion injury

Molecular Medicine

Volumn 20, Issue JULY-DECEMBER 2014, 2014, Pages 448-455

  Huang, Jing ^a,b   Shen, Xiu Da ^a   Yue, Shi ^a   Zhu, Jianjun ^a   Gao, Feng ^a   Zhai, Yuan ^a   Busuttil, Ronald W ^a   Ke, Bibo ^a   Kupiec Weglinski, Jerzy W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGINASE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NOTCH1 RECEPTOR; PROTEIN KINASE B; STAT3 PROTEIN; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HES1 PROTEIN, MOUSE; HMOX1 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE; NOTCH1 PROTEIN, MOUSE; STAT3 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY PHENOTYPE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL DIFFERENTIATION; CHEMICAL MODIFICATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EX VIVO STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HISTOPATHOLOGY; IN VIVO STUDY; INTRACELLULAR SIGNALING; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; LIVER CELL; LIVER INJURY; LIVER PROTECTION; MALE; MOLECULAR DYNAMICS; MORPHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SCORING SYSTEM; SUZUKI HISTOLOGICAL SCORE; UPREGULATION; ANIMAL; BONE MARROW CELL; CYTOLOGY; GENETICS; LIVER DISEASES; MACROPHAGE; METABOLISM;

ADOPTIVE TRANSFER; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW CELLS; CELL DIFFERENTIATION; HEME OXYGENASE-1; HOMEODOMAIN PROTEINS; LIVER DISEASES; MACROPHAGES; MALE; MEMBRANE PROTEINS; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; PHENOTYPE; RECEPTOR, NOTCH1; REPERFUSION INJURY; STAT3 TRANSCRIPTION FACTOR;

EID: 84921900425     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2014.00103     Document Type: Article

References (48)

1. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. (2011) Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune- mediated tissue inflammation. Am. J. Transplant. 11:1563–9.
2. Ke B, et al. (2012) HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling. J. Hepatol. 56:359–66.
3. Zhai Y, et al. (2004) Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173:7115–9.
4. Ke B, et al. (2002) Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum. Gene Ther. 13:1189–99.
5. Amersi F, et al. (1999) Upregulation of heme oxygenase- 1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Invest. 104:1631–9.
6. Ke B, et al. (2003) Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/ reperfusion injury are heme oxygenase-1 dependent. Am. J. Transplant. 3:1076–82.
7. Ke B, et al. (2007) Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity. Hum. Gene Ther. 18:355–66.
8. Kato H, et al. (2001) Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am. J. Transplant. 1:121–8.
9. Patel A, et al. (2004) Early stress protein gene expression in a human model of ischemic preconditioning. Transplantation. 78:1479–87.
10. Devey L, et al. (2009) Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. Mol. Ther. 17:65–72.
11. Li N, et al. (2000) Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidantresponsive element. J. Immunol. 165:3393–401.
12. Itoh K, et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:313–22.
13. Reichard JF, Motz GT, Puga A. (2007) Heme oxygenase- 1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Res. 35:7074–86.
14. Ma Q. (2013) Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53:401–26.
15. Nioi P, McMahon M, Itoh K, Yamamoto M, Hayes JD. (2003) Identification of a novel Nrf2- regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem. J. 374:337–48.
16. McMahon M, Itoh K, Yamamoto M, Hayes JD. (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278:21592–600.
17. Nguyen T, Nioi P, Pickett CB. (2009) The Nrf2- antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284:13291–5.
18. Hagemann JH, Thomasova D, Mulay SR, Anders HJ. (2013) Nrf2 signalling promotes ex vivo tubular epithelial cell survival and regeneration via murine double minute (MDM)-2. Nephrol. Dial. Transplant. 28:2028–37.
19. Cho HY, et al. (2002) Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26:175–82.
20. Jin W, et al. (2009) Genetic ablation of Nrf2 enhances susceptibility to acute lung injury after traumatic brain injury in mice. Exp. Biol. Med. (Maywood). 234:181–9.
21. Institute of Laboratory Animal Resources (U.S.), Committee on Care and Use of Laboratory Animals. (1985) Guide for the Care and Use of Laboratory Animals. Rev. 1985. Bethesda (MD): NIH. 83 pp. (NIH publication; no. 85-23).
22. Shen XD, et al. (2002) CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase- 1 mediated cytoprotection. Transplantation. 74:315–9.
23. Ke B, et al. (2010) Adoptive transfer of ex vivo HO-1 modified bone marrow-derived macrophages prevents liver ischemia and reperfusion injury. Mol. Ther. 18:1019–25.
24. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. (1993) Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation. 55:1265–72.
25. Mullane KM, Kraemer R, Smith B. (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods. 14:157–67.
26. Zhang Q, et al. (2012) Notch signal suppresses Tolllike receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signalegulated kinase 1/2-mediated nuclear factor kappaB activation. J. Biol. Chem. 287:6208–17.
27. Klaassen CD, Reisman SA. (2010) Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. Toxicol. Appl. Pharmacol. 244:57–65.
28. Johnson JA, et al. (2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 1147:61–9.
29. Zhang Y, Gordon GB. (2004) A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol. Cancer Ther. 3:885–93.
30. Shan Y, Lambrecht RW, Donohue SE, Bonkovsky HL. (2006) Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J. 20:2651–3.
31. Lee TS, Chau LY. (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8:240–6.
32. Ke B, et al. (2013) KEAP1-NRF2 complex in ischemia- induced hepatocellular damage of mouse liver transplants. J. Hepatol. 59:1200–7.
33. Rushworth SA, MacEwan DJ, O’Connell MA. (2008) Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes. J. Immunol. 181:6730–7.
34. Artavanis-Tsakonas S, Rand MD, Lake RJ. (1999) Notch signaling: cell fate control and signal integration in development. Science. 284:770–6.
35. Kohler C, et al. (2004) Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration. Hepatology. 39:1056–65.
36. Yu HC, et al. (2011) Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling. Hepatology. 54:979–88.
37. Monahan P, Rybak S, Raetzman LT. (2009) The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary. Endocrinology. 150:4386–94.
38. Moriyama M, et al. (2006) Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J. Cell Biol. 173:333–9.
39. Radtke F, et al. (1999) Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 10:547–58.
40. Strom A, Castella P, Rockwood J, Wagner J, Caudy M. (1997) Mediation of NGF signaling by post-translational inhibition of HES-1, a basic helix-loop-helix repressor of neuronal differentiation. Genes Dev. 11:3168–81.
41. Weng AP, et al. (2003) Growth suppression of pre- T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol. Cell. Biol. 23:655–64.
42. Murata K, et al. (2005) Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1. Mol. Cell. Biol. 25:4262–71.
43. Datta SR, et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:231–41.
44. Scheid MP, Woodgett JR. (2001) PKB/AKT: functional insights from genetic models. Nat. Rev. Mol. Cell. Biol. 2:760–8.
45. Nicholson KM, Anderson NG. (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 14:381–95.
46. Kim AH, Khursigara G, Sun X, Franke TF, Chao MV. (2001) Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21:893–901.
47. Sica A, Bronte V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117:1155–66.
48. Kamakura S, et al. (2004) Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat. Cell Biol. 6:547–54.